Comparing the current results to its competitors, Acutus Medical Inc reported Revenue increase in the 4 quarter 2024 by 283.9 % year on year. The sales growth was above Acutus Medical Inc 's competitors' average revenue growth of 6.61 %, achieved in the same quarter.
Acutus Medical Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 56.73 %
Acutus Medical Inc 's Comment on Competition and Industry Peers
The company faces indirect competition in the electrophysiology field from competitors of Medtronic in heart access products, including Abbott Laboratories, Biosense Webster Inc. (a Johnson & Johnson company), and Boston Scientific Corporation. These competitors are large, well-capitalized firms with greater market share and resources. Key competitive factors in this field include name recognition; relationships with healthcare professionals, customers, and third-party payors; quality and extent of distribution networks; product line breadth; ability to offer rebates or bundled discounts; capabilities in research and development, manufacturing, clinical trials, marketing, and regulatory approval; and financial and human resources for product development, manufacturing, sales, marketing, and patent prosecution.
Retractable Technologies Inc. is a medical device manufacturing company that specializes in the production of retractable needle systems. Their business model revolves around developing and distributing innovative safety medical products that protect healthcare workers from accidental needlestick injuries. By offering a range of retractable needle solutions, they aim to improve workplace safety and reduce the potential transmission of bloodborne diseases.
Stereotaxis Inc's business model involves developing and providing robotic technologies for use in medical procedures, particularly in the field of electrophysiology.
Staar Surgical Co employs a business model focused on developing, manufacturing, and distributing implantable lenses used for the treatment of refractive errors such as myopia and astigmatism. The company primarily sells its products to eye surgeons and ophthalmologists globally, generating revenue through product sales and royalties from licensing agreements. By constantly innovating and expanding its product portfolio, Staar Surgical Co aims to improve vision outcomes for patients and maintain a competitive position in the ophthalmic market.
Surmodics Inc operates on a business model centered around the development and commercialization of innovative medical device and pharmaceutical technologies. The company focuses on creating surface modification technologies, such as drug delivery coatings, that enhance the performance and functionality of medical devices and improve therapeutic outcomes. Surmodics Inc collaborates with industry partners to license or directly manufacture and sell their proprietary products in various medical fields.
Sources:
Acutus Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Acutus Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
